Patents Assigned to BioSurface Engineering Technologies, Incle
  • Patent number: 8227411
    Abstract: The present invention provides a fibroblast growth factor heparin-binding analog of the formula: where R1, R2, R3, R4, R5, X, Y and Z are as defined, pharmaceutical compositions, coating compositions and medical devices including the fibroblast growth factor heparin-binding analog of the foregoing formula, and methods and uses thereof.
    Type: Grant
    Filed: February 23, 2006
    Date of Patent: July 24, 2012
    Assignees: BioSurface Engineering Technologies, Incle, Brookhaven and Science Associates
    Inventors: Paul O. Zamora, Louis A. Pena, Xinhua Lin, Kazuyuki Takahashi